Detalhe da pesquisa
1.
Data-driven approach to mitigate quality impact of hygroscopic pharmaceutical raw materials throughout the supply chain.
Pharm Dev Technol
; 27(5): 511-524, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702831
2.
Reproducibility of the Measurement of Bulk/Tapped Density of Pharmaceutical Powders Between Pharmaceutical Laboratories.
J Pharm Sci
; 108(3): 1081-1084, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30326209
3.
Discovery and in Vivo Evaluation of Macrocyclic Mcl-1 Inhibitors Featuring an α-Hydroxy Phenylacetic Acid Pharmacophore or Bioisostere.
J Med Chem
; 62(22): 10258-10271, 2019 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31736296
4.
Applications of Powder X-Ray Diffraction in Small Molecule Pharmaceuticals: Achievements and Aspirations.
J Pharm Sci
; 107(12): 2969-2982, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30145209
5.
Assessment of defects and amorphous structure produced in raffinose pentahydrate upon dehydration.
J Pharm Sci
; 96(5): 1418-33, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17455351
6.
Salt disproportionation: A material science perspective.
Int J Pharm
; 520(1-2): 228-240, 2017 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28163222
7.
Maximizing the Impact of Physiologically Based Oral Absorption Modeling and Simulation.
J Pharm Sci
; 106(3): 734-737, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27915208
8.
Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors.
J Med Chem
; 59(1): 431-47, 2016 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26652588
9.
Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430).
J Med Chem
; 59(15): 7252-67, 2016 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27411843
10.
Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease.
J Med Chem
; 58(1): 480-511, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25469863
11.
Improved pharmacokinetics of AMG 517 through co-crystallization part 2: analysis of 12 carboxylic acid co-crystals.
J Pharm Sci
; 100(7): 2734-43, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21287556
12.
Improved pharmacokinetics of AMG 517 through co-crystallization. Part 1: comparison of two acids with corresponding amide co-crystals.
J Pharm Sci
; 99(9): 3769-78, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20665842
13.
Characterization of amorphous API:Polymer mixtures using X-ray powder diffraction.
J Pharm Sci
; 97(11): 4840-56, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18351626